⚡ ASX Catalyst Report

oOh!media Limited — New Zealand Overseas Investment Office consent has been received, satisfying one condition of I Squared Capital's proposed A$1.68-per-share acquisition of oOh!media. The scheme still requires FIRB approval, shareholder and court approval, so the stock's immediate upside is largely limited to closing the current spread.
⚠ Most of the takeover value is already reflected in the price; only a 1.8% gross spread remains. FIRB, shareholder and court approvals are outstanding, and the 15:57 announcement timing limits same-day momentum. The scheme remains subject to no superior proposal and the independent expert maintaining its conclusion.
💡 Use a small merger-arbitrage long for the approximately 1.8% gross spread, with position size constrained by the remaining FIRB, shareholder and court risks and an exit before the spread is fully compressed.

— Routine quarterly update with no new material catalyst, while the 42,000oz resource was previously announced and the capital raise was modest.

Zenith Minerals Limited — Zenith's directors unanimously recommend Forrestania Resources' off-market takeover offer for Zenith shares, subject only to no superior proposal, after the offer became free from all defeating conditions on 22 October 2026. The offer closes at 5:00pm AWST on 12 November 2026, but this is the sixth supplementary target's statement and largely formalises an already-known transaction status rather than introducing a new bid premium or competing proposal.
⚠ Follow-up announcement after multiple prior supplementary target's statements; the offer became unconditional yesterday, so much of the certainty may already be priced in; no offer price, premium or new consideration is stated in the supplied extract; late-day 15:19 release; thin turnover limits execution and exit quality; recommendation remains conditional on no Superior Proposal.
💡 Only take a small, highly liquid position for a short-term takeover-certainty trade if the market price remains below the implied offer value; avoid chasing in the thin tape and monitor Forrestania's share price and any superior-proposal risk.

Orpheus Uranium Limited — Orpheus has completed its acquisition of the Oobagooma Uranium Project in Western Australia, where historical drilling recorded up to 3,775 ppm eU3O8 over 1.65 metres and several other intersections above 2,000 ppm. The project adds shallow roll-front uranium mineralisation and regional strategic interest, but the announcement contains no new drilling, resource estimate, acquisition valuation or immediate development milestone.
⚠ Historical results only; narrow intersections; eU3O8 equivalent data rather than new laboratory assays; no JORC resource or defined Exploration Target yet; no acquisition consideration or economic terms disclosed; Heathgate activity is indirect regional evidence, not a project commitment; follow-up announcement released after another price-sensitive announcement earlier today; announcement released late in the trading session; average turnover of only A$32k/day makes execution highly difficult.
💡 Avoid chasing this late-day, illiquid follow-up; only consider a very small speculative long if volume expands materially and the company delivers a defined Exploration Target or fresh drilling results, with limited near-term sympathy potential from Australian uranium explorers.

— Early-stage fieldwork and target generation are encouraging, but assay results and drilling remain pending with no immediate discovery or resource news.

— Routine quarterly report highlighting a heavily dilutive placement, no exploration results, and low cash balance.

EverGold Minerals Limited — EverGold reported strong previously disclosed Mt Monger drilling results, including 25m at 3.47 g/t Au and 6m at 5.43 g/t Au at Duchess of York, plus a new Vanguard zone with lower-grade mineralisation. The report also outlined further drilling toward a maiden resource targeted for early 2027, but contains no genuinely new assay catalyst and was released after the main intraday volatility window.
⚠ Most impressive assays were previously announced and are not new today; Vanguard grades are modest; some shallow high grades may reflect supergene enrichment; no maiden resource yet; report released at 13:15 AEST; average turnover of only A$29k makes the stock effectively untradeable for normal position sizes; live market data shows cash of $648k versus $2.8m in the announcement, requiring verification.
💡 Do not chase this low-liquidity quarterly report; wait for a fresh resource-definition result or maiden resource catalyst, with any move toward 10%+ best treated as a speculative scalp rather than a standard long.

— Routine quarterly report with modest anomalous gold results and pending follow-up assays, unlikely to drive a major move today.

Janus Electric Holdings Limited — Janus Electric has secured A$11 million of CBA facilities, comprising a A$10 million revolving trade finance facility and A$1 million asset finance facility. The funding is intended to support production and delivery of its North American order book, including the first US truck conversions from a 118-truck order book scheduled for 2Q FY2, subject to conditions.
⚠ Secured debt is not the same as revenue or a firm delivery contract; facilities are subject to annual CBA review, financial covenants, security over company assets, interest and fees, and drawdown conditions. The 118-truck order book remains conditional and delivery timing is forward-looking. Cash runway of approximately 1.7 quarters implies an imminent equity raise, creating sell-the-strength risk. Existing debt of A$6.8m increases balance-sheet risk.
💡 Take a small tactical long only if volume expands and the stock holds above A$0.50, targeting a same-day momentum move, while avoiding oversized exposure because the likely equity raise and lack of immediate revenue confirmation can reverse the move.

— Routine issue of rights-issue shortfall shares at $0.002, providing no new operational catalyst.

Supply Network Limited — Supply Network reported another strong FY26, with revenue rising to $403.1m, EBIT increasing to $69.4m and NPAT reaching $47.6m. The presentation also outlined substantial branch, distribution-centre and technology expansion, but this is a follow-up AGM presentation after an earlier price-sensitive announcement today rather than a fresh surprise catalyst.
⚠ Follow-up announcement after earlier price-sensitive news today; AGM presentation rather than a new hard catalyst; no material FY27 earnings guidance upgrade; mature $1.54b company limits percentage upside; $43.0m debt versus $18.7m cash is manageable but reduces balance-sheet leverage to expansion. Strong historical results may already be reflected in the prior announcement.
💡 Do not chase the midday follow-up; only consider a small long on a volume-backed breakout above the recent range, otherwise wait for a pullback because the positive fundamentals are not a sufficiently fresh catalyst for an aggressive intraday trade.

— Routine address reiterating previously reported strong FY2026 results with no material new catalyst.

Geopacific Resources Limited — Geopacific has secured access to up to A$8 million of unsecured bearer bonds from its 47%-shareholder Deutsche Balaton AG to fund Woodlark development and project-financing work toward FID. The funding supports a 1.98 Moz gold project with a DFS forecast of over 100,000 ozpa, below A$2,000/oz AISC, A$1.3 billion post-tax NPV and 50.6% IRR, but the facility carries a high 15% interest rate and matures on 30 June 2027.
⚠ High 15% financing cost; bonds mature on 30 June 2027; funding is progressive rather than fully drawn; no FID or project finance package has been secured; Woodlark remains exposed to Papua New Guinea execution and jurisdiction risk; cash runway implies an imminent capital raise despite this facility; average turnover is extremely poor; DFS economics are forward-looking and previously disclosed rather than new information.
💡 Do not chase the announcement in size; only consider a very small speculative long if volume expands materially, otherwise wait for a funded FID or strategic partner, with no meaningful sympathy trade unless the broader gold-development group re-rates.

— A routine monthly unfranked distribution announcement with no new operational or financial catalyst.

Orbital Corporation Limited — Orbital reported Q1 revenue of A$3.4 million, expanded its customer base to 16 and secured multiple UAV propulsion orders, including three systems from L&T and three from MightyFly. The most material development is AATI becoming Orbital's first Power by the Hour customer, generating US$2.6 million (A$3.7 million) of contracted revenue through December 2027, although the company remains cash-constrained and faces imminent funding risk.
⚠ Imminent capital raise risk with approximately 1.1 quarters of cash runway; A$6.1m debt; very poor liquidity with only A$11k average daily turnover; announcement is a follow-up after another price-sensitive release earlier today; some opportunities remain conditional, including the unresolved US military retrofit program and potential future L&T production orders; released at 11:26 AEST after the strongest opening momentum window.
💡 Only take a small speculative long if volume expands materially above normal, targeting an intraday momentum move while avoiding any chase because the imminent raise could reverse strength; the UAV and defence customer wins may provide sympathy to comparable Australian defence-tech and autonomous-aviation names.

— Solid SaaS growth and cash improvement are positive, but overall revenue and earnings growth are modest and routine.

AML3D Limited — AML3D reported $16.8 million of orders rolling into FY27, up 87% from $9.0 million previously, with customer receipts of $3.0 million, up 19% year-on-year. The quarter included a new approximately $0.5 million US Navy submarine production-parts order, progress on the existing $9.9 million Newport News Shipbuilding contract, and participation in a $3.9 million aerospace R&D project.
⚠ Quarterly-report format may limit headline impact; several positive figures relate to previously announced orders rather than fresh surprises. The $80 million-plus sales pipeline and up-to-1,600-component US Navy demand are not equivalent to firm contracted revenue. The aerospace project is developmental and explicitly not expected to generate direct revenue. Execution, delivery timing and the $12 million US capacity expansion remain key risks.
💡 Take a modest long position for a same-day to multi-day momentum trade, adding only if volume expands materially above the $356k average; the US Navy and AUKUS exposure may also lift sympathy in small-cap Australian defence technology names.

— Routine annual meeting notice with no new operational, financial or corporate catalyst disclosed.

Steadfast Group Limited — The Supreme Court of NSW approved the convening of Steadfast's shareholder Scheme Meeting and distribution of the Scheme Booklet for the proposed acquisition by Dragoneer- and KKR-backed Starboard BidCo. The Independent Expert concluded the Scheme is in shareholders' best interests absent a superior proposal, while the Board unanimously recommends approval; the Scheme Meeting is scheduled for 27 November 2026 with implementation expected on 22 December 2026.
⚠ Procedural follow-up rather than a fresh takeover premium; exact Scheme Consideration is not stated in the supplied release; upside is capped by the scheme price and downside remains if shareholders reject the scheme, a superior proposal emerges, or implementation is delayed. The stock is already close to the Independent Expert's upper valuation range.
💡 Use only a small long takeover-arbitrage position for the spread to the undisclosed Scheme Consideration, rather than chasing the announcement; the large-cap float and procedural nature make a sharp momentum breakout unlikely.

ikeGPS Group Limited — IKE reported 1H FY27 platform subscription revenue of approximately NZ$11 million, up 22% year-on-year, with subscription revenue representing 85% of total revenue and exit run-rate subscription growth guided above 30% for FY27. However, professional services revenue fell 61% year-on-year, and the update contains no major upgrade to near-term recognised revenue guidance, making this a constructive but non-transformational follow-up announcement.
⚠ Follow-up announcement with limited incremental surprise; A$31k average daily turnover makes the stock effectively untradeable for normal sizing; professional services revenue declined 61% year-on-year; recognised subscription revenue guidance is deferred until end-November; headline subscription growth may be diluted by weaker non-recurring revenue.
💡 Avoid chasing this follow-up update; only consider a very small long if volume expands materially and the stock holds above A$0.815, with the stronger setup likely deferred until November guidance or a new-product revenue milestone.

Lithium Universe Limited — CEO Iggy Tan and CTO Dr Jingyuan Liu have both resigned and will leave on 30 October 2026, with no specific reason provided and no replacement CEO appointed. The company says its lithium refinery and recycling technology strategies remain ongoing, but the simultaneous departure of its two key executives creates meaningful execution and strategy risk.
⚠ Simultaneous CEO and CTO departures with no explanation; no replacement CEO or detailed succession timetable; potential loss of project and technical knowledge; lithium sector and LIT ETF proxy are weak; extremely poor liquidity makes both entry and exit difficult; prior five-day decline creates partial priced-in risk.
💡 Avoid a normal-sized short because A$8k daily turnover makes execution and covering hazardous; experienced traders should treat any opening bounce as an exit/avoidance signal, with downside likely targeting A$0.004, while monitoring for peer sympathy only across other weak lithium developers.

— Routine proposed rebranding requiring shareholder approval, with no new financial or operational catalyst.

Kinetiko Energy Limited — Kinetiko reported adoption of the Phase 1 Brakfontein Field Development Plan, progress toward gas permitting and a target of first commercial gas in late 2027. The quarter also included a A$5.4 million placement at A$0.03 per share and A$1.26 million of non-dilutive funding from Mulilo, but most milestones were previously announced and the company remains heavily cash constrained.
⚠ Routine quarterly report with no new production, resource or permitting approval; FDP adoption was previously announced on 1 July 2026; first commercial gas is not targeted until late 2027; permit submission and approval remain outstanding; South African permitting and execution risk; 130 million placement shares remain to be issued; related-party exposure because A$3.0 million of the placement was committed by an entity associated with non-executive director Mxolisi Mgojo; cash runway remains very short despite the committed placement; average turnover of only A$7k makes the stock untradeable for meaningful size.
💡 Avoid chasing this report: only consider a very small speculative long if volume expands materially above the A$0.03 placement price, otherwise wait for the permit submission or a firm production/offtake milestone; there is no compelling peer-sympathy angle from this update.

Reef Casino Trust — RCT has lodged its formal Target's Statement responding to Iris Cairns Property's off-market bid for all units it does not already own. The independent directors unanimously recommend acceptance, subject to no superior proposal and the independent expert maintaining its conclusion that the offer is fair and reasonable; the offer closes at 7:00pm on 9 November 2026.
⚠ The takeover was announced on 24 September, so much of the value may already be priced in. The supplied text omits the offer price and consideration, preventing calculation of the arbitrage spread. Recommendation remains conditional on no superior proposal and the independent expert not revoking its opinion. Average turnover of only A$33k makes execution and exit difficult.
💡 Treat this as a small takeover-arbitrage long only if the market price remains meaningfully below the unstated offer value; use minimal size and avoid chasing because the A$33k turnover makes the position difficult to enter or exit.

Bass Oil Limited — Bass Oil reported September-quarter production of 23,944 barrels, up 20.9% quarter-on-quarter, with sales revenue increasing 4.4% to A$2.82 million. Bunian 6 has commenced production and Indonesian field output is now approximately 700 bopd on a JV-share basis, while the Vanessa gas restart remains targeted for year-end. The update is positive operationally but largely confirms previously outlined growth projects rather than delivering a major new financial surprise.
⚠ Routine quarterly update rather than a transformational catalyst; Bunian 6 was online for only one week of the quarter; Vanessa gas is still awaiting regulatory and restart works; Cooper Basin sales fell 20.9% due to rain-related road closures; cash declined to A$2.07 million; no quantified Vanessa gas production, reserves uplift or project economics; prior five-day price rise of 12.3% creates partial priced-in risk; average daily turnover of only A$47k makes the stock effectively untradeable for normal-sized positions; announcement says debt free while live market data shows A$1.7 million of debt.
💡 Only take a small speculative long if volume expands materially above normal, targeting a short intraday-to-multiday move on the Bunian 6 and Vanessa growth narrative; avoid chasing a thin open because execution and exit risk outweigh the modest fundamental surprise.

— Trading is paused pending further news, but the announcement provides no details indicating a catalyst.

— Routine highly speculative bonus and piggyback option issuance with no new operational catalyst.

— Routine quarterly report with no definitive customer agreements, results, funding catalyst or other material new development.

Challenger Gold Limited — Challenger Gold has completed the first US$15 million tranche of unsecured convertible debentures and has secured agreements for total gross proceeds of US$30.3 million, potentially increasing to US$35.0 million. The debentures convert at an initial A$2.72 per share, a 34% premium to the current A$2.03 price, funding Hualilan development and working capital through mid-2027 while the company works toward full project financing.
⚠ Convertible debt creates future dilution and the detailed interest, maturity and adjustment terms are not provided in the announcement. The US$9.3 million Tranche 2 remains conditional on shareholder approval, and the company still needs to complete full Hualilan project financing by mid-2027. The announcement also contains substantial forward-looking language around the updated PFS, production timing, recoveries and capital reductions; these are not yet proven operational outcomes. The raise was foreshadowed on 28 September, limiting surprise value.
💡 Take only a small long into the open or on a volume-backed break above A$2.10, targeting a short-term funding-relief move toward A$2.20-A$2.30; avoid chasing because the conversion structure and pending shareholder approval can cap upside.

European Metals Holdings Limited — European Metals has given in-principle approval to replace two gas-fired rotary kilns in the Cinovec DFS with one gas/electric tunnel kiln. The company expects materially lower processing-plant capex and opex, reduced gas dependence and emissions, but provides no quantified savings and the decision remains subject to further testwork contracts and procurement consultation.
⚠ No quantified capex or opex savings; in-principle approval only; final gas-versus-electric choice remains unresolved; subject to testwork contracts and Czech public procurement consultation; pre-revenue company has only A$721k cash and likely imminent funding risk; average turnover of A$7k is effectively untradeable; lithium sector ETF proxy is down 13% over one month and 11% over three months.
💡 Do not chase the opening move in this illiquid stock; only consider a very small speculative long if volume expands materially, with a short-term exit, while recognising the likely equity raise overhang and limited lithium-sector sympathy.

— Provides near-term working capital but is a secured, high-cost loan rather than transformational operational news.

— Routine quarterly report highlighting project progress and drilling commencement but no assay results, discovery, or other major catalyst.

dorsaVi Limited — dorsaVi commercially launched Sensor v6.5, an on-device wearable platform providing movement analysis and configurable biofeedback without cloud connectivity. The company also completed FEOL and MOL fabrication for an RRAM-CMOS validation chip, commenced RRAM energy measurements and announced a A$3.0 million placement after quarter-end, but the RRAM technology remains unintegrated, untested and pre-commercial.
⚠ Routine quarterly framing; no new revenue, customer, contract or commercial adoption data; RRAM remains early-stage and unvalidated; robotics opportunity is exploratory with no named partner or financial terms; placement-related dilution and future funding risk remain; A$21k average turnover means exiting a A$5k parcel could materially move the stock.
💡 Do not chase the pre-open headline; only consider a very small speculative long if volume expands dramatically and the stock holds above the opening range, otherwise wait for evidence of Sensor v6.5 sales or RRAM electrical validation.

Orpheus Uranium Limited — Orpheus reported a routine September quarter cash flow statement, with net operating and investing outflows of A$2.271 million and A$4.25 million raised through equity issuance. Cash increased to A$6.655 million, providing a comfortable runway, but there are no new drilling results, resource developments or other material operating catalysts.
⚠ Routine quarterly report with no exploration results or operational milestone; uranium sector momentum is weak; average daily turnover of only A$32,000 makes execution difficult; equity raise may create supply overhang despite improving cash runway.
💡 Do not chase this routine report; only consider a very small speculative position if later exploration news creates volume, with no attractive intraday trade while turnover remains this low.

— A$1.35m placement at an 18% discount with an upcoming SPP is dilutive and typically negative despite funding strategic project milestones.

Centaurus Metals Limited — Centaurus has defined more than 20 new drill-ready copper-gold targets across its expanded 75km² Boi Novo Project in Brazil, including eight priority prospects at Rio Novo and 13 additional targets outside the existing Nelore focus area. The announcement cites strong surface geochemistry and historical drilling, but no new drill assays; drilling plans are still being developed.
⚠ No new drill assays or resource estimate; headline grades are predominantly surface rock-chip results and historical intercepts; drilling is only being planned; 'strategic pathways' is vague corporate language; Brazil jurisdiction is favourable within the Carajás Province but the stock's A$258.5m market cap limits explosive upside from target generation alone.
💡 Take a small long only if the pre-open auction holds above A$0.45 with expanding volume, targeting an intraday momentum trade rather than a long-term chase; watch Carajás copper-gold peers for sympathy, but exit quickly if the market dismisses the surface-only nature of the update.

— A routine estimated monthly distribution with no new operational or financial catalyst, and the ex-date is later.

— Routine early-stage drilling start with no new assays, while meaningful catalysts remain pending.

Australasian Metals Limited — Australasian Metals reported progress on its option to acquire up to 75% of the Atex Lithium-Tantalum Project and 51% of Alliance in Côte d’Ivoire, highlighting historical drilling of 67.97m at 1.23% Li₂O, including 27m at 2.13% Li₂O. The company also completed a $1.05 million placement at $0.13 per share, while due diligence continues and auger drilling is not expected to begin until November.
⚠ Historical drilling results are not new and were previously disclosed; no current assay or resource estimate; option remains subject to due diligence and a December decision; Alliance remains at the application stage; Côte d’Ivoire jurisdiction and licence-renewal risk; lithium sector momentum is weak; $5k average daily turnover makes the stock effectively untradeable; historical grades may not be representative of a future JORC resource.
💡 Only take a very small speculative long if volume expands materially above normal, targeting a short-term move toward the $0.13 placement price; otherwise avoid, as the premium raise and strong historical lithium grades are outweighed by stale data, weak lithium sentiment and unusable liquidity.

Orbital Corporation Limited — Orbital has secured its first Power by the Hour agreement with American Aerospace Technologies, covering a fleet growing to 10 unmanned aircraft and providing US$2.6 million (A$3.7 million) of take-or-pay revenue through 31 December 2027. The contract creates a recurring service stream with minimum commitments of 200 engine hours per aircraft per month, although further fleet expansion and the referenced US Coast Guard opportunity remain conditional.
⚠ Imminent capital raise risk may cause selling into strength; contract revenue is modest in absolute terms and no gross margin or earnings contribution is disclosed; AATI is a relatively small counterparty; fleet expansion beyond the initial 10 aircraft and Phase II are conditional; the US Coast Guard opportunity is only an RFI with no contract awarded; average daily turnover of A$11k makes the stock effectively untradeable for normal position sizing.
💡 A momentum trader could take only a small speculative long on a confirmed pre-open gap and sustained volume, targeting the first 1-2 sessions, while avoiding oversized orders because the imminent raise and extreme illiquidity can reverse the move; defence/UAV propulsion peers may receive sympathy interest.

— Routine quarterly unfranked distribution with no new information likely to cause significant intraday price movement.

— Commercial launch is a strategic milestone but provides no new customer, revenue or contract evidence.

Kip McGrath Education Centres Limited — Crimson Consulting has made its unconditional all-cash takeover offer for KME shares more attractive operationally by accelerating payment to 10 business days and extending the offer deadline to 7:00pm on 4 November 2026. The offer remains $0.75 per share, is explicitly last and final, and does not increase the bid price.
⚠ No increase to the offer price; bid is explicitly last and final; upside is limited to approximately 3.45% and may be reduced by any relevant dividend; extension may indicate the bidder still needs acceptances; deal completion and timing risk remain; thin A$112k average turnover limits position size.
💡 Treat this as a small-size takeover-arbitrage long toward A$0.75 rather than a momentum breakout, with a short holding period and strict attention to acceptance and deal-completion risk.

— A routine monthly unfranked distribution announcement is unlikely to drive significant price movement today.

Dimerix Limited — Independent analysis of 261 FSGS patients from the NEPTUNE cohort found elevated MCP-1/CCR2 pathway activity was associated with worsening kidney function and poorer outcomes, supporting the biological rationale for Dimerix's Phase 3 DMX-200 program. The data are supportive rather than efficacy-proving: ACTION3 remains ongoing and the announcement provides no new clinical endpoint, statistical effect size or regulatory approval.
⚠ Mechanistic and biomarker validation is not clinical efficacy; no new numerical patient outcome data or Phase 3 result; announcement repeatedly qualifies conclusions as subject to ACTION3 success; provisional patent has uncertain commercial value; cash runway of approximately 1.3 quarters implies an imminent capital raise and likely selling into strength; A$174.1m market cap reduces the probability of an outsized move from supportive biology alone.
💡 Take a small, short-duration long only if the pre-open auction holds above A$0.290 with expanding volume, taking profits into an initial 5-10% spike; avoid chasing because the likely capital raise can cap follow-through, while the stronger peer sympathy trade would require a positive ACTION3 result rather than mechanism data.

— Routine quarterly report with operational improvements and revenue growth but no major new financial result or transformational catalyst.

Element 25 Limited — Element 25 reported continued progress on the Butcherbird Expansion Project, targeting 1.1Mtpa of manganese concentrate, supported by a 101.4Mt ore reserve grading 10.4% Mn and an 18+ year mine life. The quarter included early site works, a binding take-or-pay offtake arrangement for up to approximately 1.1Mtpa with OM Materials, a binding AU$50 million NAIF finance facility and confirmation of a revised US$166 million US Department of Energy grant for the HPMSM development.
⚠ Quarterly-report wrapper around an offtake agreement already announced on 3 August 2026; offtake pricing and project economics are undisclosed; project financing and regulatory conditions remain; early site works are not the same as construction completion; no clear production start date or capex funding package; manganese lacks the immediate momentum of gold or copper; very thin liquidity at approximately AU$61k average daily turnover.
💡 Use only a small speculative long into the pre-open or opening auction, target a same-day momentum move and avoid chasing thin-volume spikes; the cleaner follow-through signal would be a break above recent resistance on materially higher turnover.

Elixir Energy Limited — Elixir has signed definitive agreements to farm out half of its working interests across its Taroom Trough portfolio to Beach Energy for $25 million in cash plus $180 million of carried appraisal, drilling, seismic and operating expenditure. The deal materially de-risks Elixir's acreage, provides a four-year funding pathway and brings a credible Australian gas producer into the project, although Elixir gives up half of its interests and the transaction remains subject to conditions precedent.
⚠ Headline transaction value is mostly carried expenditure rather than cash; Elixir gives up half of the relevant interests; conditions precedent remain; cash runway is only approximately 1.3 quarters and a capital raise may still be required; management's claim that the deal values resources at 3x the current trading value is promotional rather than an independent valuation; 12.8% five-day run creates partial priced-in risk.
💡 Take a small-to-medium long into the pre-open strength and scale only if volume expands materially, targeting an intraday re-rating while respecting the likely future raise; Beach Energy and other Taroom Trough gas peers may also attract sympathy buying.

— Routine first quarterly report and 4C with no material new contract, results or guidance likely to drive significant movement today.

EVT Limited — EVT reported normalised Q1 EBITDA of $72.5 million, up 17% year-on-year, driven by a major recovery in Entertainment and continued Hotels strength. Entertainment EBITDA rose 171% to $32.0 million on 19% higher admissions, while Hotels EBITDA was broadly stable at $23.9 million and Thredbo fell sharply due to the worst snow conditions in more than 40 years. EVT maintained its expectation for FY27 EBITDA growth and is pursuing approximately $800 million of property divestments over three years.
⚠ Large $1.39b debt burden and approximately $1.33b net debt limit valuation upside. FY27 outlook remains conditional on film performance, release timing, weather and broader market conditions, with no specific earnings upgrade. Thredbo EBITDA fell 31% due to poor snow, and the strategic review has produced no concrete structural transaction. Property divestments are targeted but not fully executed, and the trading figures are unaudited.
💡 Take a modest long on opening strength or a first-hour consolidation, targeting a short-term continuation move rather than chasing an outsized gap; the entertainment recovery may provide a mild positive read-through for cinema peers, but the large-cap valuation and debt profile argue for disciplined sizing.

Beach Energy Limited — Beach will farm into half of Elixir Energy's core Taroom Trough acreage, securing operated interests across more than 1,000 km2 for A$25 million in cash plus a A$90 million exploration and appraisal work-program carry. The deal materially expands Beach's position to approximately 1,481 km2 net and could support an initial 2C Contingent Resource booking during the FY27 reserves process, but it does not deliver immediate production or cash flow.
⚠ No immediate production, revenue or reserve uplift is delivered; the 3.5 Tcfe figure is a previously published contingent resource rather than a new discovery or proved reserve. Completion remains subject to regulatory approvals and pre-emptive rights, while the A$90 million carry creates future capital exposure. Beach carries substantial debt and negative free cash flow, and commerciality of the early-stage Taroom Trough play is not yet established. The recent 5.8% five-day rise creates partial priced-in risk.
💡 Use a moderate-sized long only if the pre-open auction holds above A$0.91 and volume expands, targeting an intraday continuation toward A$0.95-A$0.98 while avoiding a chase if the market treats the deal as long-dated capex rather than immediate reserves growth.

Aussie Broadband Limited — Aussie Broadband highlighted a strong FY26, with revenue up 9.2% to almost $1.3 billion, underlying EBITDA of $165.3 million at the top end of upgraded guidance, and EPS growth of 25.8%. It also reiterated a 50% increase in fully franked dividends to 6 cents per share and the previously announced $115 million on-market buyback, but the presentation contains limited genuinely new information.
⚠ AGM presentation is largely retrospective and lacks a clear new earnings upgrade or FY27 quantitative guidance; buyback was already announced; high debt of A$267.5 million versus A$125.4 million cash limits balance-sheet enthusiasm; 'trading update' in the release headline overstates the amount of new operational information. At 9% of the 52-week range, the stock is near lows, but that reflects existing valuation or business concerns that this presentation does not decisively resolve.
💡 Do not chase the open; only consider a small long on sustained volume and a break above the opening range, otherwise stand aside because the announcement is confirmation rather than a catalyst.

— Improved option terms are modestly positive, but no new exploration results or transaction catalyst makes a major move unlikely today.

Zenith Minerals Limited — The Takeovers Panel declined to conduct proceedings regarding a challenge to Zenith's recommended off-market takeover by Forrestania Resources. The decision supports Zenith's board position that Aurenne's non-binding proposed A$5 million funding package was not a superior proposal and that the Forrestania deal's exclusivity provisions remain effective.
⚠ This is procedural confirmation, not an improved takeover offer. Bid consideration and completion timing are not disclosed in the announcement, Panel reasons are still pending, and the Forrestania transaction remains subject to normal scheme or takeover completion risks. Aurenne's proposal was non-binding and conditional, so its removal may already have been partly anticipated.
💡 Take a small, catalyst-driven long only if the opening price remains below the implied Forrestania bid value, targeting a short-term move toward deal value; avoid oversized orders because A$135k daily turnover makes entry and exit difficult.

— A small non-renounceable rights issue at a speculative offer price is generally dilutive and likely to create limited positive price momentum.

Kantra Copper Limited — Underground drilling at Emily Star delivered multiple meaningful copper-gold intersections, led by 11.45m at 1.74% Cu and 5.0m at 3.07% Cu, extending mineralisation approximately 200m below the 2024 MRE. The results support further resource growth ahead of an updated Mineral Resource and Ore Reserve statement scheduled for release later this month, while Kavanagh results were comparatively weak.
⚠ Stock is already near its 52-week high, increasing sell-the-news risk. The market is likely positioning for the scheduled MRE update later this month, creating partial priced-in risk. Emily Star results are strong but mostly moderate-width intersections rather than a truly exceptional bulk-tonnage hit; the 5.0m at 3.07% Cu is narrow. Kavanagh results are low grade and do not add much immediate value. No updated resource tonnes, ounces, contained copper or economic impact are provided in this announcement.
💡 Take a modest long for the pre-open and first-hour momentum, scale out into a move above 8-10%, and avoid chasing if the stock gaps sharply because the MRE catalyst is close and the shares are already near their 52-week high.

Nido Education Limited — Nido has signed a Business Sale Agreement to acquire nine early education services operated by Edge Early Learning, representing its first acquisition under its selective acquisition strategy. The deal remains subject to regulatory approvals and lease assignments, with no purchase price, funding terms, revenue, occupancy, EBITDA or earnings contribution disclosed.
⚠ No purchase price, funding structure, EBITDA, occupancy, revenue or earnings accretion disclosed; completion depends on regulatory approvals and lease assignments; very low liquidity; substantial A$243.3m debt relative to A$6.7m cash creates balance-sheet and integration risk.
💡 Avoid chasing the open despite the low-price setup; only consider a small speculative long if volume expands materially and the market receives credible financial terms, otherwise wait for completion and earnings detail.

Hawk Resources Limited — Early laboratory assays from 106 Olympus soil samples materially contradict the historical pXRF results that identified the scandium anomaly. The maximum lab-assayed scandium grade was only 11.2ppm versus 742ppm in historical pXRF data, with the Company describing the results as very disappointing and questioning the calibration of the historic analyser.
⚠ The negative result is preliminary because only 106 of 1,267 samples have been assayed, leaving a theoretical chance of partial anomaly confirmation. However, the historical pXRF data appears broadly unreliable across multiple elements, not just scandium. Cash runway of approximately 2.4 quarters creates possible capital-raising overhang, while A$81k average turnover makes exits difficult.
💡 Look for a weak open or failed bounce to short only where borrow is genuinely available; otherwise avoid chasing due to thin liquidity and sell into weakness, with the remaining assays and Cactus copper drilling as the only credible recovery catalysts.

— A deeply discounted non-renounceable entitlement offer with free options is dilutive and likely to pressure the share price.

— A small non-renounceable rights issue at $0.039 plus a modest placement is generally dilutive and lacks a strong near-term catalyst.

FAR Limited — FAR reported US$1.73 million of cash at quarter end and no major new operational development. Woodside's Sangomar field produced 94 Mbbl/d at 99.2% reliability, while FAR has a maximum future contingent payment of US$19.8 million linked to oil prices and production.
⚠ Routine quarterly report presented as a highlight announcement; no new cash receipt or updated contingent-payment forecast; Sangomar production is naturally declining and FAR's entitlement has reduced; cash is only US$1.73m against ongoing corporate burn; possible future capital raise; average turnover of A$28k/day is severely untradeable; buy-back price of A$0.2979 may act as a near-term reference but is not a genuine demand catalyst.
💡 Do not chase the thin open; only take a small long if volume expands materially and the stock holds above A$0.2979, with the contingent-payment and strong Brent narrative providing limited sympathy to other Senegal-linked or cash-backed oil names.

Neu Horizon Uranium Limited — NHU has defined a more than 2 km electromagnetic conductor at Storvallflon in Sweden, supported by five coincident datasets including ground radiometrics, radon gas and rock-chip assays. Ground spectrometer readings commonly exceeded 500 ppm U and reached approximately 1,800 ppm U, but the only assay figure disclosed was a peak 243 ppm U3O8 rock chip, with 4,000 m of drilling planned for Q1 2027.
⚠ No drill results, no reported widths or representative grade distribution, and the 1,800 ppm figure is a selected geophysical response rather than an assay. Promotional comparison to Ronneburg is conceptual only. Very poor liquidity at approximately A$9k average daily turnover makes the stock effectively untradeable in normal size. Cash runway is only about three quarters despite management stating the current programme is funded, creating possible future raise overhang.
💡 Only use a very small speculative long if opening volume expands dramatically, take profits into any sharp low-float spike, and avoid holding through the long wait for Q1 2027 drilling; no meaningful peer sympathy trade is established yet.

The Hydration Pharmaceuticals Company Limited — HPC has launched a non-renounceable 2-for-3 entitlement offer at A$0.004 per share to raise up to A$1.435 million, with one free option for every two new shares subscribed. The issue price is stated to be approximately 33% above the recent 5-day VWAP, but the raise is non-underwritten, primarily funds working capital, and comes with substantial dilution and an imminent funding overhang.
⚠ Raise is primarily to fund working capital rather than expansion; only approximately 1.4 quarters of cash runway implies continuing financing risk; offer is non-underwritten with no minimum subscription; substantial potential dilution from the 2-for-3 issue and free options; non-renounceable entitlements cannot be traded; concurrent unmarketable-parcel sale facility may create additional supply; zero average daily turnover makes the quoted price unreliable and execution extremely difficult.
💡 Only consider a very small speculative long on an opening liquidity burst, using the A$0.004 premium issue price as the key reference, and avoid holding through the offer unless prepared for severe dilution and near-zero liquidity.

Sunrise Energy Metals Limited — Sunrise reported continued progress toward a targeted 2026 final investment decision and 2028 commercial production at Syerston, including completion of FEED and advancement of procurement and early infrastructure works. The major catalyst is a conditional commitment of up to US$400 million in 25-year debt financing from the U.S. Office of Strategic Capital, alongside a proposed Nasdaq listing and ASX CDI structure, potentially materially reducing project funding risk.
⚠ The US$400 million facility is conditional, capped at 'up to' US$400 million and not yet supported by definitive financing documents. The Nasdaq/ASX CDI scheme has multiple approval conditions and could introduce structural complexity or future dilution. Syerston still requires successful execution, permitting and a final investment decision. The stock is already near its 52-week high, increasing sell-the-news risk. The 6,000-metre Cloncurry drilling program has only commenced and provides no immediate results catalyst.
💡 Take a moderate long only if the pre-open auction holds above the prior close and volume confirms, targeting the first session rather than chasing an extended gap; the U.S. defence-backed scandium financing may also lift sympathy in Australian critical-minerals and strategic-metals developers.

Bannerman Energy Ltd — The Etango Joint Venture, owned 55% by Bannerman and 45% by CNNC Overseas Limited, has approved the Final Investment Decision for the Etango-8 uranium project in Namibia. The project is forecast to produce approximately 3.5 Mlbs of U3O8 annually from 2028, with approximately US$353 million of pre-production capital expenditure and Bannerman's construction and working-capital obligations funded from existing cash balances.
⚠ Uranium momentum is currently a headwind, with the URNM ETF proxy down 18% over one month and 25% over three months. Etango is a long-known development story, so some FID expectations may already be embedded despite the recent 5-day decline. Construction, commissioning, cost escalation and the 2028 production timeline remain execution risks; the referenced cornerstone offtake is described as a framework on market-based terms rather than a fully detailed binding offtake contract. Management promotional language such as 'world-class' and 'defining moment' is present, although the funding and FID claims are specific and verifiable.
💡 Take a long position in the opening auction or on a controlled morning pullback, using a standard parcel and a 1-3 day momentum timeframe; the clean FID/funded-construction narrative can also lift uranium developers and Namibia-focused peers, but avoid chasing an opening gap above roughly 15% given the weak uranium tape.

MaxiPARTS Limited — MaxiPARTS delivered Q1 FY27 revenue of A$72.8m, up 2.6% on the prior corresponding period, while operating net profit before tax rose 26.5% to A$4.2m. Growth was driven by higher-margin Japanese parts and Förch Australia, improved Kalgoorlie earnings, cost control and lower interest costs, with further benefit expected from the Air Brake Systems acquisition.
⚠ Unaudited management accounts; revenue growth is modest at 2.6%; no quantified FY27 earnings guidance; Kalgoorlie profit growth partly benefits from an easy start-up comparison; acquisition contribution and synergies are not quantified; thin liquidity and A$48.7m debt limit institutional participation.
💡 Take a small long position only if the opening auction holds above the pre-news range and volume expands materially, targeting an intraday momentum move while avoiding oversized exposure because A$5,000 already represents 8.2% of average daily turnover.

— The report largely recycles previously announced metallurgy and exploration results, with only a non-transformational lab-scale MREC testing agreement added.

Equus Energy Limited — Equus reports a binding conditional 10-year Gas Sales Agreement with Alcoa for approximately 50 TJ/day, or 182 PJ over the contract term, alongside approval of a further US$1.5 million of Alcoa funding for project partnering. The Equus Gas Project has 1.7 Tcf of 2C gas resources and 38 MMbbl of condensate, with pre-FEED economics showing a US$867 million NPV10 and 31% IRR, but still requires approximately US$1.25 billion of Phase 1 capital.
⚠ Most headline milestones were previously announced, making this largely a repackaged quarterly report. The GSA is conditional; the 1.7 Tcf and 38 MMbbl figures are 2C Contingent Resources, not reserves; the US$867 million NPV is pre-FID project modelling; and approximately US$1.25 billion of Phase 1 capex dwarfs the company's A$13.4 million cash balance. Development depends on securing operating, infrastructure, LNG offtake and financing partners. Average turnover of only A$67k/day creates significant execution and exit risk.
💡 Use only a small speculative long on a pre-open volume breakout, targeting a same-day momentum trade rather than a hold; avoid chasing if turnover does not expand materially because the commercial news is largely stale and the funding gap remains the dominant risk.

Patagonia Lithium Ltd — Patagonia Lithium's application for a 1,000-tonne-per-year lithium carbonate demonstration plant has passed the initial gazettal stage in Jujuy, Argentina, but still requires environmental review, stakeholder comments and a UGAMP meeting before approval. Sulzer achieved positive laboratory results using a 6:1 solvent-to-brine ratio on 510ppm lithium brine, while the Mineral Resource Estimate has been delayed by five weeks and a well 9 packer test returned only 28ppm lithium.
⚠ Initial gazettal is not final environmental or production approval; the project still faces the UGAMP meeting, stakeholder comments and a further 60-day review period. The MRE is delayed by five weeks, three scoping-study expert reports remain outstanding, and the 28ppm well 9 result is substantially below the 510ppm brine referenced elsewhere. Laboratory solvent testing does not establish commercial economics or recovery at demonstration-plant scale. Thin average turnover of only A$76k makes execution difficult.
💡 Avoid chasing the pre-open headline; only consider a small speculative long if volume expands materially above normal and the stock holds gains, otherwise wait for the delayed MRE or final permit, with no compelling peer-sympathy setup.

Eminence Minerals Limited — Eminence has completed due diligence and exercised options to earn an initial 30% interest in five Côte d’Ivoire gold projects covering approximately 1,508 km², including 871 km² of granted tenure. It will pay US$45,000 cash and issue approximately US$45,000 of shares, but the announcement contains no assay results or confirmed mineralisation; artisanal workings are mentioned but remain unsampled.
⚠ No assay results or confirmed mineralisation; artisanal workings are unverified; exploration permit applications remain subject to government approval; Côte d’Ivoire jurisdiction and vendor/project documentation create execution risk; follow-up to the 19 October announcement; imminent capital-raise risk; average turnover of only A$4k makes the stock effectively untradeable; regional major-company transactions are nearology and do not prove EMA mineralisation.
💡 Only take a very small speculative long if pre-open demand produces genuine volume, using a tight exit; otherwise avoid because the follow-up nature, absent assays and imminent raise outweigh the attractive low-market-cap setup.

Swoop Holdings Limited — Swoop has signed a binding agreement to sell its Sydney Fibre assets to Xenith Infrastructure Group for approximately A$4.5 million, subject to customary conditions including FIRB approval and expected completion in Q3 FY27. Proceeds will be used for debt reduction and working capital, improving the balance sheet but not eliminating the company's heavy leverage or imminent funding risk.
⚠ Raise imminent with approximately 1.4 quarters of cash runway; sale is conditional on FIRB approval and other conditions; completion is distant in Q3 FY27; no EBITDA, profit, asset book value or transaction multiple disclosed; A$4.5m proceeds do not resolve the A$28.4m debt burden or A$24.8m annual cash burn; extremely poor liquidity at only A$6k average daily turnover.
💡 Only take a very small speculative long into the pre-open reaction and sell strength quickly; the low-price setup and 22% market-cap transaction may attract attention, but the imminent raise and untradeable liquidity make this unsuitable for a normal-sized momentum position.

X2M Connect Limited — X2M has secured 60-day binding exclusivity over a Queensland site for a proposed 10MW AI-enabled data centre with development approval and an existing 2.5MW grid connection. The project has an estimated total cost of A$250 million, taking X2M's capacity under agreement to 20MW and aggregate prospective project costs above A$500 million, but commercial terms and binding long-form agreements remain outstanding.
⚠ Commercial terms, customer identity, funding structure, margin and delivery economics are undisclosed. The headline A$250m project cost is not equivalent to X2M revenue or enterprise value. The agreement is only exclusivity for 60 days, with long-form contracts not yet signed. The full 10MW power supply depends on new behind-the-meter generation that is not expected until the end of 2028. Potential token revenue share is speculative and promotional. Cash of A$1.3m against approximately A$5.5m annual free-cash-flow burn implies an imminent raise, creating a serious sell-into-strength overhang.
💡 Take a small speculative long only if the pre-open auction confirms strong demand, do not chase a vertical spike, and trade the AI data-centre sympathy bid while exiting into strength before the 60- to 90-day contracting and capital-raise risks crystallise.

QMines Limited — QMines has completed the sale of its wholly owned drilling subsidiary, QDrilling, to Gas Field Services for total consideration of $1.4 million. The sale simplifies operations and keeps the existing rig at Mt Chalmers, but most consideration is deferred and the announcement contains no new drilling results, resource upgrade or production milestone.
⚠ Deferred consideration means only part of the $1.4 million is immediate cash; the final $250,000 may be paid in drilling services rather than cash. No new assays or economic data were released, and the 129-hole drilling campaign is only underway. Thin average turnover of A$87k/day creates meaningful entry and exit slippage. The sale could also be interpreted as an ordinary corporate simplification rather than a value-creating catalyst.
💡 Take only a small speculative long into the pre-open reaction, using strength for a quick trade rather than holding for a sustained re-rate; the real upside catalyst remains future Mt Chalmers drilling results, with limited immediate sympathy potential across copper-gold peers.

Paradigm Biopharmaceuticals Limited — Paradigm's Administrators have applied for up to a three-month extension to the deadline for convening the second creditors' meeting, giving more time to assess sale and recapitalisation proposals. This preserves a potential pathway to continuing as a going concern, but no proposal has yet advanced to a stage that can be put to creditors; without the extension, the Administrators say they would recommend winding up the company.
⚠ Company remains in voluntary administration; extension is only an application and is not yet approved; no viable sale or recapitalisation proposal has been advanced; liquidation remains the stated fallback; pending independent analysis of the Phase 3 PARA_012 trial adds clinical uncertainty; recapitalisation would likely be highly dilutive; cash burn and raise risk remain substantial.
💡 Treat any speculative relief bounce as a sell rather than chase a long, using small size and a short intraday timeframe because the extension could temporarily create a survival bid but does not remove the liquidation and dilution risks.

Whitehaven Coal Limited — Whitehaven delivered a solid Q1 FY27 operational result, with managed ROM production up 22% year-on-year to 11.0Mt, unit costs at the low end of guidance and average achieved prices up 20% year-on-year to A$226/t. However, equity sales fell 5% quarter-on-quarter to 6.0Mt due to export terminal disruptions, inventories rose 34% to 4.077Mt and net debt remained around A$1.4 billion.
⚠ Routine quarterly report rather than a guidance upgrade or earnings surprise; QLD equity sales fell 12% quarter-on-quarter; export terminal disruptions at RG Tanna and PWCS caused sales slippage; equity coal stocks rose 34% quarter-on-quarter to 4.077Mt; net debt remains approximately A$1.4 billion; no quantified cash-flow upgrade was provided.
💡 Take a modest long only if the opening auction holds above A$7.65 and volume expands, targeting a same-day 2-6% move; avoid chasing if terminal-disruption concerns dominate, as there is no obvious peer sympathy catalyst beyond a broad coal-price read-through.

— Routine quarterly report with modest cash-burn improvement and US retail expansion plans but no immediate material financial or commercial catalyst.

Canterbury Resources Limited — Canterbury reported four further Briggs copper assay results, led by 386.6m at 0.20% Cu from 43m in hole 26BRD0046, including several narrower zones grading 0.25%-0.31% Cu. The results support resource infill and the PFS but largely confirm an existing low-grade resource rather than deliver a new discovery or material grade surprise.
⚠ Low-grade copper intersections are being presented with very large widths; the 0.20% Cu over 386.6m result is broad but economically modest. Results are primarily infill drilling designed to upgrade an existing MRE, not a discovery. Mineralisation is reported down-hole rather than true width. The announcement uses promotional language around one of Australia's largest undeveloped copper projects, while the stock is extremely illiquid and vulnerable to artificial spikes and difficult exits. Molybdenum is described as two to four times above the resource average, but the absolute grades are not emphasised. No immediate raise pressure is evident, with approximately 4.8 quarters of cash runway.
💡 Avoid a standard position because A$5k average turnover makes execution impractical; only consider a very small speculative pre-open momentum trade if volume expands dramatically, with no chase and a tight exit, while watching Alma Metals for sympathy.

Acusensus Limited — Acusensus has secured a new five-year ACT Government traffic-enforcement contract worth approximately A$63m, with two further five-year extension options that could lift estimated total value to A$210m. The deal expands Acusensus from a specialist detection provider into a broader enforcement partner covering speed, average speed, red-light, mobile-phone and seatbelt enforcement, although rollout is not expected to begin until mid-2027.
⚠ The A$210m figure depends on two optional extensions and should not be valued as secured revenue. The initial A$63m is spread over five years, rollout does not begin until mid-2027, and management has disclosed no gross margin, EBITDA or free-cash-flow impact. Government contract execution, deployment timing and potential budget or regulatory delays remain risks. The stock is liquid enough for standard parcels but is too large for extreme small-cap percentage moves.
💡 Take a moderate long position into the pre-open strength or on a controlled first pullback, targeting an intraday momentum move while treating the A$210m option value as upside optionality rather than booked revenue.

— A small placement at $0.039 plus a same-price rights issue provides working capital but is routine and potentially dilutive, with no immediate operational catalyst.

Proteomics International Laboratories Ltd — Proteomics International will commence national private-pay availability of its Promarker D and Promarker Eso blood tests through Healius collection centres on 26 October 2026, following a controlled Western Australian and Northern Territory release. Patient prices are $495 for Promarker D and $997 for Promarker Eso, while Promarker Endo is targeted for commercial release in January-March 2027, but the company explicitly says revenue cannot yet be reliably estimated.
⚠ No disclosed revenue, test volumes, margins, reimbursement or Healius commercial commitments; private-pay pricing may limit adoption; early-stage commercialisation; Promarker Endo remains a future target subject to clinical, quality, accreditation and regulatory requirements; cash burn implies possible capital raise within a year; average turnover is effectively untradeable for normal position sizing.
💡 Only take a small speculative long on a volume expansion above normal turnover, targeting a short-term Monday-to-week move; avoid chasing an illiquid spike and wait for actual test-volume or revenue evidence before sizing up.

Fenix Resources Ltd — Fenix has closed out its 480,000-tonne Australian dollar iron ore hedge book for more than A$10 million in cash, comprising approximately A$8.5 million received during October 2026 and A$1.7 million settling in November. The move removes price protection through June 2027 and gives Fenix greater exposure to prevailing spot iron ore prices.
⚠ The A$10 million is a hedge monetisation gain, not recurring operating revenue. Closing the hedge book removes downside protection on 480,000 tonnes through June 2027, leaving earnings more exposed if iron ore weakens. Debt of A$128.8 million remains material, and the market may view the transaction as financial housekeeping rather than a fundamental production upgrade.
💡 Take a moderate long position into the pre-open or early-session reaction, targeting a one- to three-day relief move, but avoid chasing above 10% because the gain is non-recurring and the stock lacks a strong iron ore momentum backdrop.

Arovella Therapeutics Limited — Arovella has reached clinical readiness for its lead allogeneic CD19 CAR-iNKT therapy, ALA-101, with two GMP batches released, two trial sites active and patients being screened ahead of expected first dosing in October 2026. The company also reported A$11.6 million quarter-end cash, a further A$4.03 million R&D rebate received in October, and positive progress in preclinical ALA-105 solid-tumour studies.
⚠ No human clinical data yet; first dosing is only expected rather than confirmed; first-in-human safety risk remains substantial; preclinical ALA-105 language is promotional and results are still pending; extremely low A$42k average daily turnover creates severe entry and exit risk; large 956.1m-share free float limits squeeze potential.
💡 Take only a small speculative long on a volume-backed pre-open or opening-auction bid, targeting a same-day momentum trade and avoiding any chase if turnover does not expand materially; the next genuine catalyst is confirmed dosing or early safety/biological activity data.

BluGlass Limited — BluGlass reported continued commercial progress, including an A$1.4 million Phase II contract with Uviquity, an approximately A$286,000 early-stage collaboration with a global photonics leader, and additional liquidity from an A$8.0 million R&D financing facility. The update improves funding visibility and supports the GaN laser commercialisation story, but most of the positive items were previously announced and there is still no confirmed product-scale revenue or supply contract.
⚠ Most positive developments were previously announced; the global photonics collaboration is early-stage and only expected to run for three to five months; no binding future product-supply agreement or material revenue guidance is provided; financing carries an expensive 16.5% interest rate; average turnover of A$94k makes the stock thin and prone to sharp reversals.
💡 Use a small speculative long only if the pre-open auction holds above A$0.245 with expanding volume, targeting a short-term momentum move toward A$0.27-A$0.28 while exiting quickly if turnover fails to expand; there is no clear peer-sympathy trade until a larger GaN or defence-photonics contract is announced.

Alkane Resources Limited — Alkane delivered a solid Q1 FY27, producing 40,740 gold equivalent ounces at an AISC of A$2,805/oz, generating A$102 million of mine operating cash flow and ending with A$440 million in cash and bullion. FY27 guidance was reaffirmed, while shareholders received a maiden 2-cent fully franked dividend and the company approved a A$50 million buyback.
⚠ Near 52-week highs, so reaffirmed guidance may be largely priced in and could produce a sell-the-news reaction. No production or cost guidance upgrade was provided. Exploration commentary is promotional but lacks specific assay grades and widths. The announcement cites A$440 million cash and bullion versus A$459 million including listed investments, which is positive but should not be conflated with cash alone.
💡 Use a modest long position for the pre-open and first-hour momentum, taking profits into a 3-5% pop unless management upgrades guidance on the 10:00am webcast; this is a quality producer confirmation trade, not a high-beta discovery setup.

— The excerpt contains only presentation cover and disclaimers, with no new financial, operational or guidance information to drive a significant move.

Zip Co Limited — Zip delivered strong operating growth, with 1Q27 TTV up 18.0% to $4.6b, revenue up 17.0% to $376.1m and US TTV up 34.1% in USD. However, reported cash EBTDA rose only 3.4% to $65.0m after a $10.1m fraud-related cost, while net bad debts increased to 1.97% of TTV from 1.65%, creating a mixed-quality result despite reaffirmed FY27 cash EBTDA guidance of $340m.
⚠ Fraud event generated $10.1m of operating costs and temporarily disrupted US growth; net bad debts deteriorated to 1.97% of TTV; reported cash EBTDA growth was only 3.4%; cash NTM declined 22bps; active customers were flat year on year and Australian active customers fell 6.9%. The company also carries substantial net debt of approximately $2.55b, which increases sensitivity to funding and credit conditions. Results are unaudited management figures and guidance reaffirmation is less powerful than an upgrade.
💡 Take a moderate long in the pre-open or opening-auction strength for a 1-3 day momentum trade, but reduce quickly if bad-debt concerns dominate; the clean US growth and reaffirmed guidance can support sympathy in other BNPL and fintech names.

Newmont Corporation — Newmont lodged its Form 8-K and ASX notice relating to third-quarter 2026 results for the period ended 30 September 2026. The supplied announcement contains no revenue, earnings, production, cost, guidance or dividend figures, so it provides no assessable earnings surprise or new operating catalyst.
⚠ The supplied filing omits the attached earnings release's actual financial and operating figures, making the catalyst impossible to validate. Large-cap market capitalisation limits percentage upside from routine results, and the live gold tape is weakening.
💡 Do not chase the ASX open on this filing alone; wait for the full earnings figures and conference-call guidance, then trade only a genuine production, cost or outlook surprise with a tight risk-defined position.

— Routine Form 10-Q filing notice with no highlighted new catalyst or material results.

Temple & Webster Group — Temple & Webster reported record FY26 revenue of A$665m, up 11%, and EBITDA of A$21.9m, up 17%, with adjusted EBITDA rising 28% to A$25.9m. More importantly for the market, management is targeting FY27 EBITDA of A$33–40m, implying approximately 50–80% growth, while retaining A$123m of cash after a A$30m buy-back.
⚠ FY27 guidance is aspirational and presented as a wide A$33–40m range; discretionary furniture demand remains exposed to consumer weakness; strategic reduction of entry-level ranges could create short-term volume pressure; AGM presentation contains strategy and long-term market opportunity claims that may be discounted without quarterly execution evidence.
💡 Buy only on a strong opening auction or orderly breakout above the pre-announcement range, using a standard position for a 1–3 day momentum trade; the near-52-week-low positioning and 50–80% FY27 EBITDA growth target create a credible re-rating setup, but avoid chasing an opening spike without confirmation.

— Routine AGM addresses and strategy commentary contain no clearly new price-sensitive results, contract or capital action.

— Planned CEO departure and interim chair appointment are administrative with no immediate operational catalyst.

Black Cat Syndicate Limited — Black Cat produced 16,740oz of 100% company gold and 19,153oz including third-party production in the September quarter, maintaining FY27 guidance of 80-90koz at AISC of A$3,500-3,900/oz. The report contains a strong near-mine result of 4.8m at 18.8g/t Au at Lynx and A$39m of positive operating cash flow, but production fell from 20,830oz in the prior quarter and cash and liquid assets declined to A$77.6m.
⚠ Routine quarterly report with mixed operating performance; production fell approximately 20% quarter-on-quarter; AISC of A$3,735/oz is high; cash and liquid assets declined materially; Lynx result is a single 4.8m near-mine intercept rather than a transformational discovery; Kal East had less-than-optimal geological knowledge and mine performance; resource and reserve grade reductions were acknowledged; gold commodity tape is currently neutral and down 6% over one month.
💡 Do not chase the pre-open report; an experienced trader would remain neutral and only consider a small long if the stock reclaims the prior close on strong volume, while monitoring other Australian gold producers for sympathy from the high-grade Lynx result.

Bhagwan Marine Limited — Bhagwan Marine reported Q1 FY27 revenue of A$81.3 million, up 14% on the previous quarter and 32% on the prior corresponding period. Growth was driven by high-margin Offshore Energy & Resources subsea work, Riverside Industrial Sands and the recently acquired Riverside Marine business, but the update does not disclose Q1 earnings, margins or upgraded guidance.
⚠ Revenue-only update with no Q1 EBITDA, NPAT, margin or FY27 guidance; AGM presentation packaging may limit the perceived novelty; A$157.6m debt against A$23.8m cash is material; average daily turnover of A$178k is thin; growth partly reflects the Riverside Marine acquisition rather than purely organic expansion; exposure to offshore energy remains sensitive to project timing and Middle East-related activity.
💡 Take a small long only if the opening auction holds above A$0.300 and volume expands materially, targeting an intraday momentum move toward A$0.315-A$0.330; avoid chasing a thin-volume spike and monitor listed marine, offshore services and energy-infrastructure peers for sympathy strength.

Stavely Minerals Limited — Stavely reiterated a major Thursday's Gossan Scoping Study with a pre-tax NPV7 of A$818 million, 40% IRR, 2.5-year payback and approximately A$110 million average annual free cash flow, against a market capitalisation of only A$13.4 million. Freddy's Find also returned 13.7m at 1.80g/t AuEq, including 1m at 7.03g/t AuEq, but most of the economic study content appears to recap previously released news and the project requires approximately A$472 million of development and pre-strip capital.
⚠ Very low liquidity at approximately A$8k average daily turnover; announcement largely recycles the previously released Thursday's Gossan Scoping Study; scoping-stage economics are not a feasibility study; A$472m combined development and pre-strip capital requirement creates substantial future financing or strategic-partner risk; no metallurgical testwork has yet been completed for gold and silver recovery; AuEq assumptions use forecast metal prices rather than current spot; reported quarter-end cash of A$2m differs from live-market cash data of A$3.1m; the 1m at 7.03g/t AuEq interval is narrow and buried within a broader lower-grade result.
💡 Only take a very small speculative long if turnover expands dramatically and price breaks above the recent range; otherwise avoid the A$5k parcel because the stock is effectively untradeable, with the better medium-term angle being a strategic-partner or funding announcement rather than this recycled quarterly report.

Argent BioPharma Ltd — Argent reported A$734,000 of quarterly operating outflows, received A$600,000 under its convertible securities facility and entered into a further US$500,000 unsecured loan facility. The company also highlighted the CannEpil® global licence, including US$5.5 million of convertible-note forgiveness, a 15% human-sales royalty and a new 10% veterinary royalty, but these developments appear largely previously announced and no clinical approval, revenue milestone or efficacy data was delivered.
⚠ Routine quarterly-report framing around largely previously announced licensing developments; no clinical efficacy, regulatory approval or material revenue reported; FDA INAD file is only an initial regulatory milestone and not approval; approximately 0.3 quarters of cash runway creates imminent raise and dilution risk; substantial debt and continuing reliance on convertible funding; A$21,000 average turnover makes entry and exit impractical.
💡 Avoid taking a normal-sized position despite the low-float setup; only a tiny speculative momentum trade on a volume surge above several times average turnover is justified, while experienced traders should expect any strength to be sold into funding risk rather than chase the stale licensing narrative.

— Routine early-stage drilling update with no assay results or immediate economic data.

— Routine Appendix 5B showing cash burn with no new operational results, funding, or catalyst.

Mineral Resources Limited — MinRes delivered a solid Q1 FY27 operational update, with record Mining Services production of 103Mt, Onslow Iron attributable shipments of 5.0M wmt at a better-than-guided $53/wmt FOB cost, and record attributable lithium sales of 170k dmt SC6. Net debt fell to approximately $4.1b, liquidity increased to $2.5b, Fitch upgraded the company to BB, and ASIC closed its investigation without enforcement action, although the Lithium CEO resigned and FY27 guidance was not upgraded.
⚠ Routine quarterly report with no guidance upgrade; Lithium CEO resignation creates management uncertainty; elevated Mt Marion and Bald Hill costs; diesel prices rose to approximately $1.60/litre and are expected to pressure future FOB costs; gross debt remains high at $5.8b; POSCO lithium transaction is still subject to conditions precedent; weak lithium and iron ore sector tapes may limit multiple expansion.
💡 Use a modest long bias into the pre-open auction or on a hold above the initial range, targeting a 1-3 day move, but keep size controlled because this is a large-cap confirmation report rather than a major earnings surprise.

Ora Banda Mining Ltd — Ora Banda reported 33,305 oz of gold production and 33,939 oz sold for the September quarter, while construction of its new 3.0 Mtpa processing plant and high-grade Waihi Underground development commenced on schedule or ahead of schedule. However, quarterly AISC was elevated at A$4,214/oz due to wet weather and an extended mill shutdown, with FY27 guidance merely maintained rather than upgraded.
⚠ Large-cap stock requiring substantial earnings surprise for a major move; gold tape is currently neutral with gold down 6% over one month; AISC of A$4,214/oz is elevated; FY27 guidance was maintained rather than upgraded; 'DRIVE to 300' is explicitly aspirational and not a production target; $133.7m of quarterly growth and development spending creates execution and commissioning risk; stock is already up 4.5% over five days and sits at 75% of its 52-week range.
💡 Take a modest long only if the opening auction holds above the pre-announcement price and volume expands, targeting a one-to-three-day continuation toward the 52-week high; avoid chasing because this is execution progress without a guidance upgrade, while gold-peer sympathy should be limited by the neutral bullion tape.

Alma Metals Limited — Alma reported four infill holes from the Briggs copper MRE, led by 386.6m at 0.20% Cu from 43m, including 40.6m at 0.31% Cu. The results broadly confirm the existing geological model and may support conversion of Inferred Resources to Indicated ahead of a resource update and PFS, but they do not represent a new discovery or a material economic milestone.
⚠ Infill drilling rather than a new discovery; copper grades are moderate for a porphyry project; reported intersections are down-hole and may not represent true widths; molybdenum by-product value is asserted but not quantified economically; no updated resource, PFS economics or mine-development milestone yet; average turnover of only A$22k/day creates severe entry and exit risk.
💡 Only consider a very small speculative long into the pre-open reaction and sell strength, because the broad confirmation may attract a brief retail bid but A$22k average turnover makes a normal parcel impractical; no meaningful peer sympathy trade is likely from these non-discovery results.

— Routine quarterly report showing exploration cash burn and no material new catalyst.

— Routine quarterly update with positive exploration and funding details but no major new results or transformational catalyst.

— Provides routine progress on a previously announced US$15 million sale, with key approvals still outstanding and no completed transaction.

Talisman Mining Limited — Talisman reported broad but low-grade shallow gold intersections at the Sheepyard Prospect, including 9m at 0.94g/t Au and 15m at 0.55g/t Au, across an approximately 800m unconstrained strike length. The company has completed a $4.0 million capital raising and plans follow-up RC drilling in November, but most of the drilling results were previously announced and the report provides no immediate discovery or resource milestone.
⚠ Results are largely recycled from the 27 July announcement; grades remain sub-economic-looking exploration grades rather than discovery-grade intercepts; AC drilling does not provide a definitive depth test; the strongest mineralisation is associated with shallow, broad low-grade zones; RC drilling is only planned for November; average turnover of A$7k/day makes the stock effectively untradeable; capital raising pricing and discount are not disclosed in this report.
💡 Do not chase the pre-open reaction; only consider a very small speculative long if volume expands materially, otherwise wait for November RC results, with no meaningful peer-sympathy trade because the grades are not yet sector-defining.

— A small, non-underwritten SPP at $0.021 is a routine discounted capital raising with likely dilution and limited immediate catalyst impact.

— A small $500,000 SPP is routine financing and offers no clear near-term catalyst, with potential dilution pressure.

IKE GPS Group Limited — IKE reported Sep YTD platform subscription revenue of approximately NZ$11.0m, up 22% year-on-year, with subscription revenue representing approximately 85% of total revenue and annualised exit-rate subscription revenue of approximately NZ$22.0m. The company now expects FY27 subscription revenue growth to land below the previously indicated approximately 35%, although exit-rate subscription growth is forecast at more than 30%; three new products remain on track for launch in 2H FY27.
⚠ FY27 recognised subscription revenue growth is now expected below the previously indicated approximately 35%; exact full-year growth will not be confirmed until the end of November. Contract timing creates forecast uncertainty, while the three new products are still pre-launch and expected to contribute materially only from FY28. Average daily turnover of just A$31k makes the stock untradeable for a normal A$5k parcel and can produce wide spreads and unreliable price discovery.
💡 Avoid chasing the pre-open reaction because of the A$31k average turnover; only consider a small long after price confirmation if November guidance restores the 35% growth trajectory, otherwise wait for a liquid breakout rather than treating the product pipeline as an immediate catalyst.